Please wait while we load the price list

Business Wire - Questcor Reports Results of a Phase II Study of Emitasol in Diabetic Gastroparesis

January 12th, 2009

Business Editors & High Tech Writers
HAYWARD, Calif.–(BUSINESS WIRE)–Oct. 19, 2000
Questcor Pharmaceuticals Inc. (AMEX:QSC) announced today the results of the Phase II study of Emitasol(R) (Metoclopramide, Nasal Spray) in the treatment of diabetic gastroparesis, a serious complication of diabetes that substantially reduces quality of life. The study found encouraging results in terms of safety and a preliminary evaluation of efficacy.
In this open-label, multic…

Clinical Psychiatry News - Metoclopramide treats Tourette’s

January 6th, 2009

A daily dose of metoclopramide decreased tic severity by 38.7% in children aged 7-18 years with Tourette’s disorder, compared with a 12.6% reduction in a placebo group, reported Rob Nicholson, M.D., of the University of Western Ontario in London, and his colleagues.
In a randomized, double-blind, placebo-controlled study of 27 children, 14 received metoclopramide starting at…

Clinical Psychiatry News - Metoclopramide may suppress Tourette’s tics

January 3rd, 2009

DENVER — The dopamine receptor antagonist metoclopramide shows potential as a tic suppressant in patients with Tourette’s syndrome according to a small preliminary study, Dr. Maria T. Acosta reported at the annual meet…

Internal Medicine News - One-step test for gastroparesis guides metoclopramide use

December 27th, 2008

Los ANGELES — A one-step procedure can be used to diagnose gastroparesis and identify the best candidates for metoclopramide therapy.
The determination is based on gastric emptying time, which can be calculated by feeding patients scrambled eggs laced with a radioactive tracer. Scintigraphy is then used to observe and quantify the passage of the eggs through the stomach.
T…

Clinical Psychiatry News - Migraine role seen for metoclopramide

December 26th, 2008

Metoclopramide is an effective migraine treatment for adults–as few as four patients need to be treated to enable one to achieve significant pain reduction. But other antiemetics may have more effect on pain and migraine-related nausea, according to Ian Colman, a postgraduate student at the University of Cambridge (England), and his colleagues.
Their metaanalysis included five studies of metoclopramide vs. placebo (263 adults); three studies of metoclopra…

Nutrition Health Review - Dopamine linked to psychosis - Medical News From Around The World - Brief Article

December 22nd, 2008

TAIWAN–As reported in Annals of Pharmacotherapy (September 2002), symptoms of psychosis developed in two patients after treatment with the dopamine receptor antagonist metoclopramide.
One of the patients, a 65-year-old man, had been given metoclopramide for gastric stasis. He had a history of cerebrovascul…

News: Salix Announces Appointment of Mark Sirgo to Board of …

December 17th, 2008

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced the
appointment of Mark A. Sirgo, Pharm. D., to the Company’s Board of
Directors.

Dr. Sirgo has over 25 years pharmaceutical industry experience
spanning clinical drug development, executive management, business
developme…

Ginger Herb - Dosage and Useful Properties-herbal Medicines

December 14th, 2008

Taxonomic Class

Zingiberaceae

Common Trade Names

Multi-ingredient preparations: Cayenne Ginger, Gingerall, Ginger Ease, Ginger Peppermint Combo, Ginger Power, Ginger Root Alcohol Free, Ginger Trips, Low Alcohol Misty Ginger Blend

Common Forms

Capsules, liquid, powder: 100 mg, 465 mg

Fabry Disease – Information on Fabry Disease

December 11th, 2008

Fabry disease is caused by the lack of or faulty enzyme needed to metabolize lipids, fat-like substances that include oils, waxes, and fatty acids. The enzyme is known as ceramide trihexosidase, also called alpha-galactosidase-A. A mutation in the gene that controls this enzyme causes insufficient breakdown of lipids, which build up to harmful levels in the eyes, kidneys, autonomic nervous system, and cardiovascular system.

Since the gene that i…

JPEN: Journal of Parenteral and Enteral Nutrition - Gastric Motility Function in Critically Ill Patients Tolerant vs Intolerant to Gastric Nutrition

December 6th, 2008

ABSTRACT. Background: Administration of gastric enteral nutrition (EN) in the intensive care unit (ICU) is commonly impeded by high gastric residual volumes (GRV). This study evaluated gastric emptying in patients with limited GRV (tolerant group) vs volumes 150 mL (intolerant group) and whether prokinetic therapy improves gastric motility in intolerant patients. Me…